Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Investigate the Effect of Different Durations of Ameluz Application on Response to Treatment of Acral Actinic Keratoses

NCT03963102 is registered in ClinicalTrials.gov with Royal Cornwall Hospitals Trust as lead sponsor.

NCT NCT03963102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03963102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Investigate the Effect of Different Durations of Ameluz Application on Response to Treatment of Acral Actinic Keratoses
Lead sponsor
Royal Cornwall Hospitals Trust
Phase
Phase 4
Overall status
Terminated
Start date
October 30, 2019
Completion date
March 31, 2024
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratoses, photodamaged skin